The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Liver biopsy in chronic hepatitis

International Conference Reporter from

11th World Congress of Gastroenterology (WCOG)

Vienna, Austria

September 10, 1998

Liver biopsy in chronic hepatitis – why do it?

Dr P Scheuer, London, UK, provided strong arguments for the continued use of liver biopsy in diagnosis, pre- and post-treatment assessment, follow up, and research, in chronic hepatitis.

Biopsy adds much to liver function tests in diagnosis, and is essential for total assessment. Although HCV RNA in serum is now often used for diagnosis of Hepatitis C, biopsy can give more insight into the nature of disease, showing extent of inflammation and cirrhosis. Biopsy can also illustrate which disease is responsible for liver damage in cases of e.g. hepatitis plus thalassaemia.

In assessing patients’ need for treatment, biopsy is also useful. Originally, pathologists had difficulty in classifying hepatitis by histology alone, but a number of grading and staging systems have been used over the years. Clinicians require a numerical evaluation to assist their decisions to treat, and the simple algorithm of the METAVIR group has been very useful. This has a range of 0-3, and does not detect minor histological changes. On the other hand, the Knodell updated scoring allows a cumulative grading of 0-18, and a staging of 0-6. However, a ‘grading total’ figure should not be used to assume the need for therapy, since these numbers are not true measurements, but a hierarchy of gradings.

Although largely unnecessary for detecting cirrhosis nowadays, biopsy is still often used to do so. Pathology is also useful in identifying hepatocellular carcinoma when there is not obvious tumour mass, and negative serum alpha-fetoprotein.

Liver tissue is essential to cell-based research studies, such as analysis of cytotoxic lymphocytes in a diseased organ. Various in situ staining techniques obviously need tissue sections to be useful. As a concluding note, Dr Scheuer referred to a study which had shown that progression of fibrosis is related to age of the patient at infection, duration of disease, high alcohol intake, and male sex – purely derived by a sophisticated scoring system of biopsy pathology.